Marker Therapeutics, Inc.
MRKR
$1.19
$0.00030.03%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 16.92% | 64.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.92% | 64.73% | |||
| Cost of Revenue | 46.53% | 48.63% | |||
| Gross Profit | -83.43% | -32.50% | |||
| SG&A Expenses | 20.16% | -25.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 41.32% | 24.40% | |||
| Operating Income | -60.90% | -3.98% | |||
| Income Before Tax | -64.10% | -5.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -66.26% | -5.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -66.26% | -5.27% | |||
| EBIT | -60.90% | -3.98% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -61.65% | -5.21% | |||
| Normalized Basic EPS | -59.49% | -5.20% | |||
| EPS Diluted | -60.85% | -4.00% | |||
| Normalized Diluted EPS | -59.49% | -5.20% | |||
| Average Basic Shares Outstanding | 2.85% | 0.06% | |||
| Average Diluted Shares Outstanding | 2.85% | 0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||